Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-1995 | 12-1994 | 12-1993 | 12-1992 | 12-1991 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 32,736 | 23,646 | 12,533 | 16,438 | 26,243 |
| Marketable Securities | 13,418 | 26,232 | 75,748 | 66,906 | 78,052 |
| Receivables | 2,689 | 0 | 0 | 0 | 0 |
| Other current assets | 359 | 2,168 | 3,536 | 1,321 | 2,343 |
| TOTAL | $49,202 | $52,046 | $91,817 | $84,665 | $106,638 |
| Non-Current Assets | |||||
| PPE Net | 27,871 | 27,686 | 22,430 | 10,486 | 5,395 |
| Investments And Advances | 14,742 | 11,280 | 231 | 0 | 0 |
| Other Non-Current Assets | 1,996 | 3,224 | 3,102 | 2,729 | 1,981 |
| TOTAL | $44,609 | $42,190 | $25,763 | $13,215 | $7,375 |
| Total Assets | $93,811 | $94,236 | $117,579 | $97,880 | $114,013 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 0 | 91 | 0 | 0 | 0 |
| Accounts payable and accrued liabilities | 6,290 | 4,971 | 10,313 | 2,450 | 1,576 |
| Accrued Expenses | 0 | 9,752 | 333 | 0 | 324 |
| Other current liabilities | 3,167 | 0 | 833 | 1,103 | 1,006 |
| TOTAL | $12,948 | $17,866 | $13,078 | $4,556 | $3,302 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,826 | 1,909 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 103 | 0 | 0 | 0 | 1,554 |
| TOTAL | $13,007 | $9,299 | $6,113 | $6,170 | $4,471 |
| Total Liabilities | $25,955 | $27,165 | $19,191 | $10,727 | $7,773 |
| Shareholders' Equity | |||||
| Common Shares | 21 | 19 | 12 | 8 | 15 |
| Retained earnings | -124,605 | -101,098 | -70,443 | -30,559 | -11,447 |
| Other shareholders' equity | -1,154 | -763 | 6 | 6 | 0 |
| TOTAL | $67,856 | $67,071 | $98,388 | $87,153 | $106,240 |
| Total Liabilities And Equity | $93,811 | $94,236 | $117,579 | $97,880 | $114,013 |